John Fanikos, R.Ph., MBA
Take a stroll through history exploring the therapeutic options for VTE prophylaxis in medically ill patients
Jason R. Vilar, Pharm.D., BCCCP
A discussion of standard and alternative laboratory methods to measure levels of direct-acting oral anticoagulants
Zachary Stacy, Pharm.D., M.S., FCCP, BCPS
While peripheral arterial disease affects more than 8 million U.S. patients with the potential for significant cardiovascular complications and death, disease state awareness remains low.
James S. Kalus, Pharm.D., FASHP
A discussion of the complexities of re-initiating anticoagulants after a bleeding event caused by anticoagulants